Sequestration Impact Survey:
|
ASCO continues to closely monitor the far-reaching effects of sequestration across oncology practice and research. Six months ago, we asked you about the initial impact of sequestration. Results showed that practices were working hard to provide care for Medicare patients, but 50 percent of respondents reported being forced to send patients to hospitals for chemotherapy. A smaller number were not able to see Medicare patients at all. This was just one month into the budget cuts; a follow-up survey in June showed very similar results.
In light of the recent budget developments, ASCO is redoubling its efforts to urge Congress to exempt Medicare Part B drugs from sequestration—but we need your help so that Congress will fully understand the impact of these cuts to you and your patients.
Please take a few moments to complete the following brief survey by no later than Monday, November 11. If you completed our sequestration impact surveys in the past, we need to hear from you again to ensure we have the most current picture of the effects of the funding cuts on oncology practice.
Thank you for participating in this critical endeavor.
In light of the recent budget developments, ASCO is redoubling its efforts to urge Congress to exempt Medicare Part B drugs from sequestration—but we need your help so that Congress will fully understand the impact of these cuts to you and your patients.
Please take a few moments to complete the following brief survey by no later than Monday, November 11. If you completed our sequestration impact surveys in the past, we need to hear from you again to ensure we have the most current picture of the effects of the funding cuts on oncology practice.
Thank you for participating in this critical endeavor.